Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity.

The aromatase-knockout (ArKO) mouse provides a useful model to examine the role that estrogens play in development and homeostasis in mammals. Lacking a functional Cyp19 gene, which encodes aromatase, the ArKO mouse cannot synthesize endogenous estrogens. We examined the adipose depots of male and female ArKO mice, observing that these animals progressively accumulate significantly more intraabdominal adipose tissue than their wild-type (WT) littermates, reflected in increased adipocyte volume at gonadal and infrarenal sites. This increased adiposity was not due to hyperphagia or reduced resting energy expenditure, but was associated with reduced spontaneous physical activity levels, reduced glucose oxidation, and a decrease in lean body mass. Elevated circulating levels of leptin and cholesterol were present in 1-year-old ArKO mice compared with WT controls, as were elevated insulin levels, although blood glucose levels were unchanged. Associated with these changes, a striking accumulation of lipid droplets was observed in the livers of ArKO animals. Our findings demonstrate an important role for estrogen in the maintenance of lipid homeostasis in both males and females.

[1]  B. Ochoa,et al.  Regulation of bile acid synthesis by estradiol and progesterone in primary cultures of rat hepatocytes. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[2]  G. Iwamoto,et al.  Increased adipose tissue in male and female estrogen receptor-α knockout mice , 2000 .

[3]  A. Thorburn,et al.  Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism. , 2000, American journal of physiology. Endocrinology and metabolism.

[4]  S. Davis,et al.  The Role of Local Estrogen Biosynthesis in Males and Females , 2000, Trends in Endocrinology & Metabolism.

[5]  T. Saibara,et al.  Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. , 2000, The Journal of clinical investigation.

[6]  M. Horowitz,et al.  The effect of ovarian steroids and photoperiod on body fat stores and uncoupling protein 2 in the marsupial Sminthopsis crassicaudata , 2000, Physiology & Behavior.

[7]  A. Prentice,et al.  Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.

[8]  A. Rigotti,et al.  Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. Boon,et al.  Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Korach,et al.  Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.

[11]  E. Rubin,et al.  Lower Plasma Levels and Accelerated Clearance of High Density Lipoprotein (HDL) and Non-HDL Cholesterol in Scavenger Receptor Class B Type I Transgenic Mice* , 1999, The Journal of Biological Chemistry.

[12]  J. Bilezikian,et al.  Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. , 1998, The New England journal of medicine.

[13]  E. Simpson,et al.  Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Hammer,et al.  Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα , 1998, Cell.

[15]  S. Davis,et al.  Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. , 1997, The New England journal of medicine.

[16]  K. Korach,et al.  Effect of testosterone and estradiol in a man with aromatase deficiency. , 1997, The New England journal of medicine.

[17]  C. Darimont,et al.  Influence of Estrogenic Status on the Lipolytic Activity of Parametrial Adipose Tissue in Vivo: an in Situ Microdialysis Study. , 1997, Endocrinology.

[18]  A. Genazzani,et al.  Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. , 1997, The Journal of clinical endocrinology and metabolism.

[19]  P. Björntorp,et al.  Mechanisms Behind Insulin Resistance in Rat Skeletal Muscle After Oophorectomy and Additional Testosterone Treatment , 1996, Diabetes.

[20]  R. Surwit,et al.  Pharmacologic Manipulation of ob Expression in a Dietary Model of Obesity (*) , 1996, The Journal of Biological Chemistry.

[21]  M. Mori,et al.  Estrogen increases hypothalamic neuropeptide Y (NPY) mRNA expression in ovariectomized obese rat , 1996, Neuroscience Letters.

[22]  J. Simpkins,et al.  Estradiol enhances brain glucose uptake in ovariectomized rats , 1995, Brain Research Bulletin.

[23]  E. Simpson,et al.  Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. , 1995, The Journal of clinical endocrinology and metabolism.

[24]  C. Malloy,et al.  Use of proton spectroscopy for detection of homozygous fatty ZDF-drt rats before weaning. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[25]  M. Deitel,et al.  Increased obese mRNA expression in omental fat cells from massively obese humans , 1995, Nature Medicine.

[26]  N. Tamura,et al.  Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. , 1995, The Journal of clinical investigation.

[27]  R. Unger Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications , 1995, Diabetes.

[28]  S. Yamashita,et al.  Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. , 1995, Biochemical and biophysical research communications.

[29]  H. Burger,et al.  Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. , 1995, Maturitas.

[30]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[31]  B. Spiegelman,et al.  Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link , 1994, Diabetes.

[32]  Y. Ito,et al.  A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). , 1994, The Journal of clinical endocrinology and metabolism.

[33]  C. Bouchard,et al.  Genetic and nongenetic determinants of regional fat distribution. , 1993, Endocrine reviews.

[34]  H. J. G. Gundersen,et al.  The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[35]  S. George,et al.  Gonadal regulation of corticotropin-releasing factor immunoreactivity in hypothalamus , 1988, Brain Research Bulletin.

[36]  P. Kovanen Regulation of plasma cholesterol by hepatic low-density lipoprotein receptors. , 1987, American heart journal.

[37]  J. Nielsen,et al.  The influence of sexual hormones on lipogenesis and lipolysis in rat fat cells. , 1980, Acta endocrinologica.

[38]  G. Wade,et al.  Gonadal hormones and behavioral regulation of body weight. , 1972, Physiology & behavior.

[39]  E. Poehlman,et al.  Traversing the menopause: changes in energy expenditure and body composition. , 1998, Coronary artery disease.